Navigation Links
Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge
Date:2/26/2009

AAP financial measure to its most directly comparable GAAP measure in the accompanying schedules, and Boston Scientific encourages investors to review these reconciliations.

Usefulness of Non-GAAP Financial Measures to Investors

The Company believes that presenting non-GAAP net income and non-GAAP net income per share, in addition to the related GAAP measures, provides investors greater transparency to the information used by Boston Scientific management for its financial and operational decision-making and allows investors to see Boston Scientific's results "through the eyes" of management. The Company further believes that providing this information better enables Boston Scientific's investors to understand the Company's operating performance and to evaluate the methodology used by management to evaluate and measure such performance.


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Boston Scientific Announces Japanese Approval for TAXUS(R) Liberte(R) Drug-Eluting Stent System
2. Biotechnology Veteran Michael Webb Joins Boston-based Investment Bank as Senior Advisor
3. Boston Scientific Acquires Labcoat Limited
4. FDA Approves Boston Scientifics Express(R) SD Renal Stent System
5. Kendle to Present at the 2008 Raymond James Boston Fall Investors Conference
6. Boston Scientific to Participate in Piper Jaffray Health Care Conference
7. Trusted LASIK Surgeons Welcomes LASIK Expert Michael Raizman of Boston to its Unique LASIK Directory
8. Idenix Pharmaceuticals to Present at Deutsche Banks 2008 Biotech Boston Confab
9. FDA Approves Boston Scientifics Apex(TM) PTCA Dilatation Catheter
10. InterMune to Present at Deutsche Bank Biotech Boston Confab
11. Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement Capability

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ia/--SinovacBiotechLtd.(SVA),aleadingdeveloperand...ointventure(JV)agreementtoestablishSinovac(Dalian)...lresearch,develop,produce,andcommercializehuman-us...erienceindevelopingandcommercializingworld-classva...ufacturingfacilitiesand,establishedoperatinginfras...
(Date:11/24/2009)... to also Visit Detroit , ..., French Ambassador for International Investment, ...y, , , , ,What: Ambassador Appia is available to ...tiatives adopted by France to further develop the ...ation and development., , ,When: Available for Int...
(Date:11/24/2009)...irstCall/--Sigma-AldrichCorporation(Nasdaq: SIAL )...December1stat1:45PMGMTinLondon,7:45AMUS/CST.Intere...ternetavailableat http://inve s tor.sig m a ...cessthisfile. ,, AboutSigma-Aldrich: Sigma-A...y.Itschemicalandbiochemicalproductsandkitsareusedi...
(Date:11/24/2009)...sia/--ShanghaiBiolaxyannouncedthe,ChineseStateFood...igationalnewdrugapplication(IND)foritsoralinsulinp...eatdiabetes.ThisIND,approvalallowsBiolaxytoinitiat...sordercharacteristicofhighbloodglucoseandpoor,meta...remicro-and,macro-vasculardiseases,lossofvision,ki...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Biolaxy Secures IND Approval for Oral Insulin 2
...d of,Directors of Shire plc (LSE: SHP, NASDAQ: SHP...cal company, announces today that David Mott will,...mediate effect. Mr Mott is Chief Executive Office...ppointed to in 2000. He joined MedImmune in 1992 a... in finance, strategic planning,business developme...
...utical Inc. (Nasdaq and SWX: BMRN) announced today...cer of BioMarin, will present a,company update at ...nce in,New York City on Wednesday, November 7, 200... a live audio webcast of the presentation,via the ...www.BMRN.com . A,replay of the presentation will b...
...ulletin Board: MODG) today announced that senior m... & Renshaw 9th Annual Healthcare Conference on,Wed...ence will be held at,the New York Palace Hotel in ...esident Shai Novik will attend.,Management will pr...evelopments. The presentation will be webcast liv...
Other Biology Technology:David Mott Appointed Non Executive Director at Shire 2David Mott Appointed Non Executive Director at Shire 3Modigene to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2
(Date:11/25/2009)...tomach, may be used to boost resistance to, or slo...hool of Medicine researchers report in a study pub...cience . , Parkinson,s disease is caused by a de...idbrain known as the substantia nigra, which is re...tion of dopamine in late-stage Parkinson,s causes ...
(Date:11/25/2009)...e officers and ambulance workers faced a terrifyin... They battled to save people from the collapsing T...and evacuated as many people as they could in an a...d making their jobs even harder was the problem of... relatives jammed mobile networks with calls and t...
(Date:11/25/2009)... is the linchpin of the environment, where atmosph..., many students see soil as "just dirt" a place t...ators are challenged with the task of helping stud...nce of soil in the environment. , A collaborati...ers at University of Nebraska-Lincoln, Oregon Stat...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2Magic box for mission impossible 2Magic box for mission impossible 3It's not just dirt! 2New nanostructure technology provides advances in eyeglass solar energy performance 14160 1New nanostructure technology provides advances in eyeglass solar energy performance 14160 2New blood tests promise simple cost effective diagnosis of gastrointestinal cancers 9987 1New blood tests promise simple cost effective diagnosis of gastrointestinal cancers 9987 2New blood tests promise simple cost effective diagnosis of gastrointestinal cancers 9987 3New blood tests promise simple cost effective diagnosis of gastrointestinal cancers 9987 4deCODE Discovers Four New Risk Factors for Prostate Cancer 5020 1deCODE Discovers Four New Risk Factors for Prostate Cancer 5020 2deCODE Discovers Four New Risk Factors for Prostate Cancer 5020 3deCODE Discovers Four New Risk Factors for Prostate Cancer 5020 4
..., Sustainable farming that employs shade trees ma...cipitation extremes that climate changes are expec...in the October issue of BioScience . The article,...rmeer, of the University of Michigan, focuses on c... be applicable to other economically important cro...
...Financial Services Provider Deploys Biometric Acce...eed for PINs or ID Cards, WALL, N.J., Sept. 30 B...I), a leader in wireless public safety,solutions a...d today that,Parente Randolph ("Parente"), a leadi...O-key,s biometric identity solution to secure thei...
..., WASHINGTON DC The Federation of American Scien...ck TM the first biologically accurate immunology ... ESA Foundation (ESAF). This bold and fun game is ...tack . , "We expect to release the next version o...egman, project manager for the FAS Learning Techno...
Other Biology News:Parente Randolph Secures Access to New Corporate Headquarters With BIO-key(R) Biometric Identification 2Parente Randolph Secures Access to New Corporate Headquarters With BIO-key(R) Biometric Identification 3Entertainment Software Association Foundation awards grant to FAS for immune attack 2
Anti-St. Louis Encephalitis (SLE, MSI-7) Monoclonal Antibody, Unconjugated, Clone 1b5d-1 from CHEMICON
Normal Hamster Serum from Equitech-Bio
UV LAMP 254 NM 8 WATT from GE Healthcare, formerly Amersham Biosciences
Mouse Anti-PEPTIDOGLYCAN Monoclonal Antibody, Unconjugated, Clone 10H6 from AbD Serotec
Biology Products: